Arrowstreet Capital, Limited Partnership Pacira Bio Sciences, Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $121 Billion
- Q3 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 1,152,625 shares of PCRX stock, worth $22.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,152,625
Previous 53,409
2058.11%
Holding current value
$22.1 Million
Previous $1.53 Million
1035.99%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PCRX
# of Institutions
263Shares Held
50.4MCall Options Held
429KPut Options Held
391K-
Black Rock Inc. New York, NY8.01MShares$154 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$102 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA4.96MShares$95.3 Million0.18% of portfolio
-
State Street Corp Boston, MA2.01MShares$38.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$38 Million0.05% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $880M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...